SCHEMBL14067780

SCHEMBL14067780

O=C1c2nc(-c3ccccc3)c(-c3ccccc3)nc2C(=O)c2nc(-c3ccccc3)c(-c3ccccc3)nc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ TP53 P04637 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ XDH P47989 5/20 0.47
▸ KDM4E B2RXH2 5/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ MAPT P10636 1/20 0.47
▸ ADORA2A P29274 2/20 0.46
▸ ADORA1 P30542 2/20 0.46
▸ GAA P10253 2/20 0.45
▸ HPGD P15428 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12767600 0.88 NPC1 (0.57) MEN1LMNAKMT2AL3MBTL1HTT
SCHEMBL65673 0.86 KMT2A (0.59) TDP1MEN1LMNAKMT2AL3MBTL1
SCHEMBL14380289 0.83 KMT2A (0.56) TDP1MEN1LMNAKMT2AL3MBTL1
SCHEMBL30395001 0.80 ALDH1A1 (0.56) TDP1MEN1LMNAKMT2AL3MBTL1
SCHEMBL31599316 0.80 ALDH1A1 (0.56) TDP1MEN1LMNAKMT2AL3MBTL1
SCHEMBL10373895 0.80 MEN1 (0.50) TDP1MEN1LMNAKMT2AL3MBTL1
SCHEMBL5239315 0.78 ADK (0.61) TDP1MEN1LMNAKMT2AL3MBTL1
SCHEMBL20831970 0.78 KDM4E (0.59) LMNAL3MBTL1KDM4EALDH1A1MAPT
SCHEMBL14380304 0.76 L3MBTL1 (0.57) TDP1MEN1LMNAKMT2AL3MBTL1
SCHEMBL14067727 0.75 MAPK14 (0.47) ALDH1A1MAPTADORA2AADORA1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968131-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE Idemitsu Kosan Co., Ltd. (JP) 2008-09-10 — — EP disclosed
US-20070160871-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2007-07-12 — — US disclosed
US-20070160871-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2007-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070160871-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE AFF4, HCN4, KCNH3 TDP1 3164/4885MEN1 1551/4885LMNA 1252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback